pubmed tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide, a dual GIP/GLP-1 receptor
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
























